PYPD
Polypid Ltd

887
Mkt Cap
$69.47M
Volume
57,168.00
52W High
$4.97
52W Low
$2.30
PE Ratio
-1.47
PYPD Fundamentals
Price
$4.37
Prev Close
$4.39
Open
$4.45
50D MA
$4.01
Beta
0.39
Avg. Volume
91,759.55
EPS (Annual)
-$4.91
P/B
2.90
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
PolyPid Ltd. (NASDAQ:PYPD) Given Average Recommendation of "Moderate Buy" by Brokerages
PolyPid Ltd. (NASDAQ:PYPD - Get Free Report) has received a consensus recommendation of "Moderate Buy" from the eight ratings firms that are currently covering the company, Marketbeat.com reports...
MarketBeat·17d ago
News Placeholder
More News
News Placeholder
PolyPid Ltd. (NASDAQ:PYPD) Short Interest Up 72.2% in December
PolyPid Ltd. (NASDAQ:PYPD - Get Free Report) was the target of a large increase in short interest in the month of December. As of December 15th, there was short interest totaling 63,411 shares, an...
MarketBeat·23d ago
News Placeholder
PolyPid Appoints Brooke Story As Chairman Of Board
(RTTNews) - PolyPid Ltd. (PYPD), a late-stage biopharma company, Tuesday announced the appointment of Brooke Story as Chairman of the Board of Directors, effective as of December 11, 2025...
Nasdaq News: Markets·1mo ago
News Placeholder
PolyPid Ltd. (NASDAQ:PYPD) Receives Average Rating of "Moderate Buy" from Brokerages
Shares of PolyPid Ltd. (NASDAQ:PYPD - Get Free Report) have earned a consensus rating of "Moderate Buy" from the eight analysts that are currently covering the firm, MarketBeat reports. One equities...
MarketBeat·1mo ago
News Placeholder
FY2025 Earnings Forecast for PolyPid Issued By HC Wainwright
PolyPid Ltd. (NASDAQ:PYPD - Free Report) - Equities research analysts at HC Wainwright decreased their FY2025 EPS estimates for PolyPid in a research note issued on Wednesday, November 12th. HC...
MarketBeat·2mo ago
News Placeholder
Roth Capital Issues Optimistic Estimate for PolyPid Earnings
PolyPid Ltd. (NASDAQ:PYPD - Free Report) - Stock analysts at Roth Capital raised their FY2025 EPS estimates for PolyPid in a research report issued on Thursday, November 13th. Roth Capital analyst B...
MarketBeat·2mo ago
News Placeholder
Wall Street Zen Upgrades PolyPid (NASDAQ:PYPD) to Hold
Wall Street Zen raised PolyPid from a "sell" rating to a "hold" rating in a report on Sunday...
MarketBeat·2mo ago
News Placeholder
PolyPid Ltd. (NASDAQ:PYPD) Given Consensus Recommendation of "Moderate Buy" by Analysts
PolyPid Ltd. (NASDAQ:PYPD - Get Free Report) has been assigned an average recommendation of "Moderate Buy" from the seven brokerages that are currently covering the firm, MarketBeat.com reports. One...
MarketBeat·2mo ago
News Placeholder
Roth Capital Lowers PolyPid (NASDAQ:PYPD) Price Target to $9.00
Roth Capital lowered their price target on PolyPid from $10.00 to $9.00 and set a "buy" rating for the company in a report on Thursday...
MarketBeat·2mo ago
News Placeholder
PolyPid (NASDAQ:PYPD) Issues Earnings Results, Beats Estimates By $0.17 EPS
PolyPid (NASDAQ:PYPD - Get Free Report) posted its earnings results on Wednesday. The company reported ($0.37) EPS for the quarter, beating analysts' consensus estimates of ($0.54) by $0.17...
MarketBeat·2mo ago
<
1
2
...
>

Latest PYPD News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.